However, at the same time, PRDX1 does protect the malignant cells from immediate death due to oxidative stress, and thus promotes the cancerous growth, which suggests that the inhibition of PRDX1 in breast cancer could be a potential therapeutic approach in this disease, especially when combined with prooxidant therapies, such as Asc/Men. This evidence concerns the gene PRDX1 and breast carcinoma.